COL1A1/COL1A2 Genes Variations Analysis
COL1A1/COL1A2 encodes the major component of type I collagen, the fibrillar collagen that is found in most connective tissues including cartilage. The COL1A1 and COL1A2 genes are located on the long (q) arms of chromosome 17 and 7 respectively. The majority of the type I collagen that is found in skin, tendon, and bone is composed of two pro-α1(I) chains and one pro-α2(I) chain. Gene mutations in type I collagen result in a deficiency of collagen for connective tissue synthesis and defects of the structure of the assembled matrix collagen in bone, tendon, ligament and skin. Mutations in the COL1A1/COL1A2 genes are the leading cause of low bone mass, osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease, idiopathic osteoporosis and atypical Marfan syndrome. Mutations in COL1A1/COL1A2 variants includes nonsense, missense, splicing, small deletions, small insertions, small indels, and complex variants.
Autosomal dominant osteogenesis imperfecta is the most common disorder and is caused by mutations in COL1A1 or COL1A2 genes, which encode the pro-α1 and pro-α2 chains of type I collagen. Individual with this disorder have fragile bones and may have short stature, loose joints, blue sclera, scoliosis, brittle teeth and hearing loss.
Mutation in the COL1A1 gene causes infantile cortical hyperostosis, commonly known as Caffey disease. This mutation results in the production of type I collagen fibrils that are variable in size and shape. Symptoms include fever, subperiosteal bone hyperplasia with swelling of the overlying soft tissues, pain. Bone abnormalities mainly affect the mandible, collarbones (clavicles), and the shafts (diaphyses) of long bones in the arms and legs.
The cardiac-valvular type and some cases of the arthrochalasia type of Ehlers-Danlos syndrome are the result of COL1A2 gene mutation. Symptoms include loose joints, joint pain, stretchy skin, and abnormal scar formation.
- Aid in the diagnosis of osteogenesis imperfect, Caffey disease and Ehlers-Danlos syndrome
- As an aid in diagnosis of Marfan Syndrome
- To identify variants of COL1A1/COL1A2 genes
- Prenatal diagnosis to identify the carrier of COL1A1/COL1A2 mutation
Negative:
- No mutation in COL1A1/COL1A2 genes, or pathogenic variant not detected
Positive:
- Point mutation and frameshift deletion/insertion in COL1A1/COL1A2 genes. It is mainly observed in osteogenesis imperfecta and Caffey Disease.
Negative for mutations analyzed (No potential pathogenic variant detected)
Real time polymerase chain reaction, Next generation sequencing, Targeted capture followed by Massively Parallel Sequencing, Bi-directional Sanger sequence analysis, Sanger sequencing.
Whole blood (Lavender top tube).
Stability
- Ambient: 72 hours
- Refrigerated: 1 week
- Frozen: Unacceptable
- Genet Med. 2006;8:383-388. [PMID: 16778601]
- Bone. 2017;102:40-49. Review. [PMID: 28232077]
- Front Genet. 2019;10:722. [PMID: 31447884]
- Am J Med Genet C Semin Med Genet. 2017;175:70-115. Review. [PMID: 28306225]
- Sci Rep. 2015;5:13468. [PMID: 26307460]
- J Clin Invest. 2005;115:1250-1257. [PMID: 15864348]
- Am J Hum Genet. 1998;62:98-110. [PMID: 9443882]